InterValve, Inc., a Minneapolis, Minnesota-based develper of an aortic valve dilation device , closed a $3m senior secured term loan agreement with Oxford Finance.
Led by Mark Ungs, chief executive officer, InterValve is dedicated to advancing innovations in aortic valvuloplasty balloon catheter designs that improve procedure safety and efficacy.
Proceeds of the loan will be used for product line expansion and the ongoing commericialization of the company’s lead product, the V8™ Aortic Valvuloplasty Balloon catheter.
Oxford Finance is a specialty finance firm that provides senior debt to life sciences and healthcare services companies.
FinSMEs
26/01/2015